INC Research Holdings, Inc. is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services. The Company's Clinical Development Services segment offers a range of clinical development services, including full-service global studies, as well as ancillary services, such as clinical monitoring, investigator recruitment, patient recruitment, data management, study reports to assist customers with their drug development process, quality assurance audits and specialized consulting services. The Phase I Services segment focuses on clinical development services for Phase I trials, which include scientific exploratory medicine, first-in-human studies through proof-of-concept stages and support for Phase I studies in established compounds.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Biotechnology & Medical Research
- Sub-Industry: N/A
- Symbol: NASDAQ:INCR
- CUSIP: N/A
- Web: www.incresearch.com
Capitalization:- Market Cap: $5.38356 billion
- Outstanding Shares: 54,181,000
Average Prices:- 50 Day Moving Avg: $56.00
- 200 Day Moving Avg: $52.66
- 52 Week Range: $40.65 - $61.10
P/E:- Trailing P/E Ratio: 31.95
- Foreward P/E Ratio: 18.40
- P/E Growth: 1.10
Sales & Book Value:- Annual Revenue: $1.03 billion
- Price / Sales: 2.75
- Book Value: $6.52 per share
- Price / Book: 8.01
Profitability:- EBIDTA: $226.74 million
- Net Margins: 5.69%
- Return on Equity: 40.69%
- Return on Assets: 9.87%
Debt:- Debt-to-Equity Ratio: 1.27%
- Current Ratio: 1.15%
- Quick Ratio: 1.15%
Misc:- Average Volume: 769,166 shs.
- Beta: 1.41
- Short Ratio: 4.84
Frequently Asked Questions for INC Research Holdings (NASDAQ:INCR)
What is INC Research Holdings' stock symbol?
INC Research Holdings trades on the NASDAQ under the ticker symbol "INCR."
How were INC Research Holdings' earnings last quarter?
INC Research Holdings, Inc. (NASDAQ:INCR) posted its quarterly earnings data on Thursday, July, 27th. The company reported $0.64 earnings per share for the quarter, hitting the consensus estimate of $0.64. The business earned $258.10 million during the quarter, compared to analysts' expectations of $256.76 million. INC Research Holdings had a return on equity of 40.69% and a net margin of 5.69%. The firm's revenue was down .3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.61 EPS. View INC Research Holdings' Earnings History.
When will INC Research Holdings make its next earnings announcement?
Where is INC Research Holdings' stock going? Where will INC Research Holdings' stock price be in 2017?
9 brokers have issued 1 year target prices for INC Research Holdings' stock. Their forecasts range from $57.00 to $68.00. On average, they anticipate INC Research Holdings' stock price to reach $63.50 in the next year. View Analyst Ratings for INC Research Holdings.
Who are some of INC Research Holdings' key competitors?
Some companies that are related to INC Research Holdings include Alnylam Pharmaceuticals (ALNY), Alkermes PLC (ALKS), Seattle Genetics (SGEN), Qiagen N.V. (QGEN), Ionis Pharmaceuticals (IONS), Icon Plc (ICLR), Exact Sciences Corporation (EXAS), Galapagos NV (GLPG), Charles River Laboratories International (CRL), United Therapeutics Corporation (UTHR), PRA Health Sciences (PRAH), ACADIA Pharmaceuticals (ACAD), Bio-Techne Corp (TECH), PAREXEL International Corporation (PRXL), FibroGen (FGEN), Puma Biotechnology (PBYI), Nektar Therapeutics (NKTR) and WuXi PharmaTech (Cayman) (WX).
Who are INC Research Holdings' key executives?
INC Research Holdings' management team includes the folowing people:
- Michael A. Bell, Executive Chairman of the Board, President - Commercial Division
- Alistair Macdonald, Chief Executive Officer, Director
- Gregory S. Rush, Chief Financial Officer, Executive Vice President
- Christopher L. Gaenzle, Chief Administrative Officer, General Counsel, Secretary
- David York Norton, Non-Executive Independent Chairman of the Board
- Todd Abbrecht, Director
- Tom Allen, Director
- Joshua Nelson, Director
- Robert W. Breckon, Independent Director
Who owns INC Research Holdings stock?
INC Research Holdings' stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (11.93%), Vanguard Group Inc. (11.42%), State Street Corp (3.27%), Janus Henderson Group PLC (3.14%), Acadian Asset Management LLC (2.45%) and Samlyn Capital LLC (1.89%). Company insiders that own INC Research Holdings stock include Alistair Macdonald, Avista Capital Partners Ii Gp,, Christopher L Gaenzle, D Jamie Macdonald, David F Burgstahler, Gregory S Rush, James T Ogle, Michael Gibertini, Robert W Breckon and Teachers Pension Plan Ontario. View Institutional Ownership Trends for INC Research Holdings.
Who sold INC Research Holdings stock? Who is selling INC Research Holdings stock?
INC Research Holdings' stock was sold by a variety of institutional investors in the last quarter, including Citadel Advisors LLC, TimesSquare Capital Management LLC, Goldman Sachs Group Inc., Bamco Inc. NY, Marshall Wace North America L.P., Boston Advisors LLC, Jennison Associates LLC and Lazard Asset Management LLC. Company insiders that have sold INC Research Holdings stock in the last year include Alistair Macdonald, Christopher L Gaenzle, D Jamie Macdonald, Gregory S Rush and Robert W Breckon. View Insider Buying and Selling for INC Research Holdings.
Who bought INC Research Holdings stock? Who is buying INC Research Holdings stock?
INC Research Holdings' stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Janus Henderson Group PLC, State Street Corp, Koch Industries Inc., Copper Rock Capital Partners LLC, Principal Financial Group Inc., Renaissance Technologies LLC and Bank of New York Mellon Corp. View Insider Buying and Selling for INC Research Holdings.
How do I buy INC Research Holdings stock?
Shares of INC Research Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is INC Research Holdings' stock price today?
One share of INC Research Holdings stock can currently be purchased for approximately $52.25.
MarketBeat Community Rating for INC Research Holdings (NASDAQ INCR)MarketBeat's community ratings are surveys of what our community members think about INC Research Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for INC Research Holdings (NASDAQ:INCR) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 5 Hold Ratings, 4 Buy Ratings |
| Consensus Rating: | Hold (Score: 2.44) |
| Consensus Price Target: | $63.50 (21.53% upside) |
Analysts' Ratings History for INC Research Holdings (NASDAQ:INCR)
Show:
| Date | Firm | Action | Rating | Price Target | Impact on Share Price | Details |
|---|
| 9/21/2017 | Mizuho | Initiated Coverage | Neutral | $57.00 | Low |  |
| 8/7/2017 | Goldman Sachs Group, Inc. (The) | Reiterated Rating | Buy -> Buy | $65.00 | Low | |
| 7/30/2017 | Jefferies Group LLC | Reiterated Rating | Hold | $62.50 | Low | |
| 6/20/2017 | William Blair | Downgrade | Outperform -> Market Perform | | High | |
| 6/5/2017 | KeyCorp | Upgrade | Sector Weight -> Overweight | $68.00 | Low | |
| 5/31/2017 | SunTrust Banks, Inc. | Upgrade | Hold -> Buy | $48.00 -> $67.00 | Medium | |
| 5/11/2017 | Robert W. Baird | Upgrade | Neutral -> Outperform | $46.00 -> $66.00 | Medium | |
| 5/3/2017 | Wells Fargo & Company | Downgrade | Outperform -> Market Perform | | High | |
| 12/19/2016 | First Analysis | Initiated Coverage | Equal -> Equal Weight | $59.00 | N/A | |
| 6/20/2016 | Credit Suisse Group | Initiated Coverage | Outperform | $51.00 | N/A | |
| 4/18/2016 | Avondale Partners | Boost Price Target | Market Perform | $39.00 -> $47.00 | N/A | |
| 3/24/2016 | J P Morgan Chase & Co | Initiated Coverage | Overweight | $47.00 | N/A | |
(Data available from 9/26/2015 forward)
Earnings History for INC Research Holdings (NASDAQ:INCR)Earnings History by Quarter for INC Research Holdings (NASDAQ INCR)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 10/30/2017 | | $0.68 | | | | | N/A | |
| 7/27/2017 | Q2 2017 | $0.64 | $0.64 | $256.76 million | $258.10 million | View | N/A | |
| 5/10/2017 | Q1 2017 | $0.55 | $0.60 | $250.76 million | $252.10 million | View | N/A | |
| 2/28/2017 | Q4 2016 | $0.67 | $0.67 | $269.00 million | $263.00 million | View | Listen | |
| 10/31/2016 | Q316 | $0.59 | $0.64 | $259.89 million | $259.56 million | View | Listen | |
| 7/27/2016 | Q216 | $0.58 | $0.61 | $252.39 million | $258.80 million | View | Listen | |
| 5/2/2016 | Q116 | $0.53 | $0.58 | $237.78 million | $249.00 million | View | Listen | |
| 2/25/2016 | Q415 | $0.49 | $0.54 | $239.31 million | $241.40 million | View | Listen | |
| 10/29/2015 | Q3 | $0.44 | $0.58 | $230.60 million | $234.50 million | View | Listen | |
| 7/30/2015 | Q215 | $0.34 | $0.47 | $219.08 million | $227.40 million | View | Listen | |
| 4/27/2015 | Q115 | $0.26 | $0.41 | $211.20 million | $308.90 million | View | Listen | |
| 2/24/2015 | Q414 | $0.21 | $0.24 | $207.88 million | $213.70 million | View | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for INC Research Holdings (NASDAQ:INCR)2017 EPS Consensus Estimate: $2.58
2018 EPS Consensus Estimate: $2.73
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|
| Q1 2017 | 3 | $0.56 | $0.64 | $0.61 |
| Q2 2017 | 3 | $0.56 | $0.64 | $0.60 |
| Q3 2017 | 4 | $0.63 | $0.70 | $0.66 |
| Q4 2017 | 5 | $0.65 | $0.75 | $0.71 |
| Q1 2018 | 1 | $0.61 | $0.61 | $0.61 |
| Q2 2018 | 2 | $0.65 | $0.72 | $0.69 |
| Q3 2018 | 1 | $0.71 | $0.71 | $0.71 |
| Q4 2018 | 1 | $0.72 | $0.72 | $0.72 |
(Data provided by Zacks Investment Research)
Dividend History for INC Research Holdings (NASDAQ:INCR)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for INC Research Holdings (NASDAQ:INCR)Insider Ownership Percentage: 0.24%
Institutional Ownership Percentage: 54.56%
Insider Trades by Quarter for INC Research Holdings (NASDAQ:INCR)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 9/18/2017 | Alistair Macdonald | CEO | Sell | 2,348 | $54.60 | $128,200.80 | |
| 9/18/2017 | Christopher L Gaenzle | CAO | Sell | 4,682 | $54.56 | $255,449.92 | |
| 9/18/2017 | Gregory S Rush | CFO | Sell | 9,703 | $54.48 | $528,619.44 | |
| 9/1/2017 | Christopher L Gaenzle | CAO | Sell | 42,601 | $58.67 | $2,499,400.67 | |
| 9/1/2017 | Gregory S Rush | CFO | Sell | 88,739 | $58.99 | $5,234,713.61 | |
| 8/30/2017 | Gregory S Rush | CFO | Sell | 41,420 | $58.26 | $2,413,129.20 | |
| 8/17/2017 | Alistair Macdonald | CEO | Sell | 8,828 | $55.65 | $491,278.20 | |
| 7/3/2017 | Alistair Macdonald | CEO | Sell | 10,555 | $58.38 | $616,200.90 | |
| 6/30/2017 | Christopher L Gaenzle | CAO | Sell | 6,873 | $58.32 | $400,833.36 | |
| 5/1/2017 | Alistair Macdonald | CEO | Sell | 9,467 | $45.00 | $426,015.00 | |
| 4/3/2017 | Christopher L Gaenzle | CAO | Sell | 4,733 | $45.70 | $216,298.10 | |
| 3/3/2017 | Alistair Macdonald | CEO | Sell | 8,828 | $45.00 | $397,260.00 | |
| 1/20/2017 | Alistair Macdonald | CEO | Sell | 1,375 | $50.50 | $69,437.50 | |
| 1/20/2017 | Christopher L Gaenzle | CAO | Sell | 1,186 | $50.09 | $59,406.74 | |
| 1/19/2017 | Gregory S Rush | VP | Sell | 2,907 | $50.57 | $147,006.99 | |
| 1/5/2017 | Alistair Macdonald | CEO | Sell | 14,840 | $52.19 | $774,499.60 | |
| 9/30/2016 | Gregory S Rush | VP | Sell | 35,503 | $44.70 | $1,586,984.10 | |
| 9/27/2016 | D. Jamie Macdonald | CEO | Sell | 53,970 | $44.30 | $2,390,871.00 | |
| 9/26/2016 | Robert W Breckon | Director | Sell | 12,197 | $44.16 | $538,619.52 | |
| 9/19/2016 | David F Burgstahler | Director | Buy | 1,000 | $43.19 | $43,190.00 | |
| 9/14/2016 | Christopher L Gaenzle | CAO | Sell | 4,734 | $43.14 | $204,224.76 | |
| 8/17/2016 | Alistair Macdonald | COO | Sell | 8,828 | $43.80 | $386,666.40 | |
| 8/4/2016 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 2,554,409 | $42.06 | $107,438,442.54 | |
| 8/4/2016 | Teachers Pension Plan Ontario | Director | Sell | 2,445,591 | $42.06 | $102,861,557.46 | |
| 8/2/2016 | D. Jamie Macdonald | CEO | Sell | 31,279 | $43.00 | $1,344,997.00 | |
| 8/1/2016 | Robert W Breckon | Director | Sell | 108 | $42.00 | $4,536.00 | |
| 7/28/2016 | Gregory S Rush | VP | Sell | 4,066 | $45.23 | $183,905.18 | |
| 7/20/2016 | D. Jamie Macdonald | CEO | Sell | 100,593 | $43.00 | $4,325,499.00 | |
| 7/15/2016 | Gregory S Rush | CFO | Sell | 5,917 | $41.50 | $245,555.50 | |
| 7/11/2016 | Alistair Macdonald | COO | Sell | 9,468 | $40.19 | $380,518.92 | |
| 7/11/2016 | Christopher L Gaenzle | CAO | Sell | 21,918 | $40.20 | $881,103.60 | |
| 7/1/2016 | Gregory S Rush | CFO | Sell | 1,358 | $37.97 | $51,563.26 | |
| 7/1/2016 | Robert W Breckon | Director | Sell | 421 | $37.97 | $15,985.37 | |
| 6/15/2016 | Christopher L Gaenzle | CAO | Sell | 7,702 | $40.14 | $309,158.28 | |
| 6/6/2016 | Michael Gibertini | Insider | Sell | 213,966 | $43.11 | $9,224,074.26 | |
| 6/2/2016 | Robert W Breckon | Director | Sell | 11,691 | $43.53 | $508,909.23 | |
| 5/6/2016 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,087,054 | $45.12 | $184,407,876.48 | |
| 5/6/2016 | Teachers Pension Plan Ontario | Director | Sell | 3,912,946 | $45.12 | $176,552,123.52 | |
| 4/18/2016 | James T Ogle | Director | Sell | 114,806 | $50.00 | $5,740,300.00 | |
| 4/12/2016 | D. Jamie Macdonald | CEO | Sell | 94,675 | $48.00 | $4,544,400.00 | |
| 4/1/2016 | Michael Gibertini | Insider | Sell | 9,000 | $40.78 | $367,020.00 | |
| 3/1/2016 | Michael Gibertini | Insider | Sell | 9,000 | $39.85 | $358,650.00 | |
| 2/4/2016 | Robert W. Breckon | Director | Sell | 3,882 | $40.03 | $155,396.46 | |
| 2/1/2016 | Gregory S. Rush | CFO | Sell | 17,752 | $40.27 | $714,873.04 | |
| 2/1/2016 | Michael Gibertini | insider | Sell | 9,000 | $40.57 | $365,130.00 | |
| 1/4/2016 | Michael Gibertini | insider | Sell | 9,000 | $46.83 | $421,470.00 | |
| 12/31/2015 | Alistair Macdonald | COO | Sell | 159,599 | $47.46 | $7,574,568.54 | |
| 12/31/2015 | Christopher L. Gaenzle | CAO | Sell | 9,468 | $48.18 | $456,168.24 | |
| 12/31/2015 | Gregory S. Rush | CFO | Sell | 35,503 | $48.17 | $1,710,179.51 | |
| 12/29/2015 | James T. Ogle | Director | Sell | 9,717 | $50.06 | $486,433.02 | |
| 12/8/2015 | Christopher L. Gaenzle | CAO | Sell | 25,185 | $41.78 | $1,052,229.30 | |
| 12/8/2015 | Gregory S. Rush | CFO | Sell | 81,035 | $45.13 | $3,657,109.55 | |
| 12/7/2015 | Alistair Macdonald | COO | Sell | 42,959 | $44.63 | $1,917,260.17 | |
| 12/7/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,597,937 | $45.00 | $206,907,165.00 | |
| 12/7/2015 | Teachers Pension Plan Ontario | Director | Sell | 4,402,063 | $45.00 | $198,092,835.00 | |
| 12/1/2015 | Michael Gibertini | insider | Sell | 9,000 | $46.52 | $418,680.00 | |
| 11/2/2015 | Michael Gibertini | insider | Sell | 9,000 | $41.70 | $375,300.00 | |
| 9/28/2015 | Alistair Macdonald | COO | Sell | 44,522 | $39.93 | $1,777,763.46 | |
| 9/14/2015 | Gregory S. Rush | CFO | Sell | 32,426 | $45.06 | $1,461,115.56 | |
| 8/31/2015 | Christopher L. Gaenzle | CAO | Sell | 17,421 | $41.16 | $717,048.36 | |
| 8/31/2015 | James T Ogle | Director | Sell | 55,000 | $41.12 | $2,261,600.00 | |
| 8/17/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 4,029,168 | $44.00 | $177,283,392.00 | |
| 8/17/2015 | Teachers Pension Plan Ontario | Director | Sell | 3,857,525 | $44.00 | $169,731,100.00 | |
| 8/12/2015 | D. Jamie Macdonald | CEO | Sell | 57,021 | $44.00 | $2,508,924.00 | |
| 8/12/2015 | Robert W Breckon | Director | Sell | 8,381 | $44.00 | $368,764.00 | |
| 5/14/2015 | Avista Capital Partners Ii Gp, | Major Shareholder | Sell | 6,599,761 | $29.68 | $195,880,906.48 | |
| 5/14/2015 | Teachers Pension Plan Ontario | Director | Sell | 6,318,607 | $29.68 | $187,536,255.76 | |
| 5/7/2015 | Gregory S Rush | CFO | Sell | 12,455 | $29.68 | $369,664.40 | |
| 5/7/2015 | Michael Gibertini | Insider | Sell | 50,000 | $29.68 | $1,484,000.00 | |
| 5/7/2015 | Robert W Breckon | Director | Sell | 8,226 | $29.68 | $244,147.68 | |
(Data available from 1/1/2013 forward)
Headline Trends for INC Research Holdings (NASDAQ:INCR)
Latest Headlines for INC Research Holdings (NASDAQ:INCR)
| Source: |
|
| Date | Headline |
|---|
 | INC Research Holdings, Inc. (INCR) Receives Average Rating of "Hold" from Brokerages
www.americanbankingnews.com - September 23 at 11:10 PM |
| INC Research Holdings, Inc. (INCR) Research Coverage Started at Mizuho
www.americanbankingnews.com - September 21 at 10:02 AM |
| Alistair Macdonald Sells 2,348 Shares of INC Research Holdings, Inc. (INCR) Stock
www.americanbankingnews.com - September 19 at 8:08 PM |
| INC Research Holdings, Inc. (INCR) CAO Christopher L. Gaenzle Sells 4,682 Shares
www.americanbankingnews.com - September 19 at 7:42 PM |
| Insider Selling: INC Research Holdings, Inc. (INCR) CFO Sells 9,703 Shares of Stock
www.americanbankingnews.com - September 19 at 7:40 PM |
| $586.58 Million in Sales Expected for INC Research Holdings, Inc. (INCR) This Quarter
www.americanbankingnews.com - September 14 at 8:20 AM |
 | Stocks Generating Improved Relative Strength: IN Cresearch
finance.yahoo.com - September 12 at 1:33 AM |
 | INC Research Holdings (INCR) Presents At Baird's 2017 Global Healthcare Conference - Slideshow
seekingalpha.com - September 8 at 11:16 PM |
| INC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : September 8, 2017
finance.yahoo.com - September 8 at 11:16 PM |
| INC Research Holdings (INCR) Presents At Wells Fargo Healthcare Conference - Slideshow
seekingalpha.com - September 7 at 8:07 PM |
| Gregory S. Rush Sells 88,739 Shares of INC Research Holdings, Inc. (INCR) Stock
www.americanbankingnews.com - September 5 at 10:26 PM |
| Insider Selling: INC Research Holdings, Inc. (INCR) CAO Sells 42,601 Shares of Stock
www.americanbankingnews.com - September 5 at 7:23 PM |
| Gregory S. Rush Sells 41,420 Shares of INC Research Holdings, Inc. (INCR) Stock
www.americanbankingnews.com - September 1 at 7:22 PM |
| IN Cresearch Sees RS Rating Improve To 73
finance.yahoo.com - August 30 at 1:28 AM |
| INC Research Holdings, Inc. – Value Analysis (NASDAQ:INCR) : August 30, 2017
finance.yahoo.com - August 30 at 1:28 AM |
| INC Research Holdings, Inc. (INCR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 29 at 11:08 PM |
| Brokerages Anticipate INC Research Holdings, Inc. (INCR) to Announce $0.62 Earnings Per Share
www.americanbankingnews.com - August 24 at 10:24 PM |
| INC Research Holdings, Inc. breached its 50 day moving average in a Bullish Manner : INCR-US : August 23, 2017
finance.yahoo.com - August 24 at 7:55 AM |
| Portola Pharmaceuticals (PTLA) and INC Research Holdings (INCR) Head to Head Contrast
www.americanbankingnews.com - August 24 at 4:08 AM |
| INC Research Holdings, Inc. (INCR) CEO Alistair Macdonald Sells 8,828 Shares
www.americanbankingnews.com - August 21 at 10:20 AM |
| Contrasting Arena Pharmaceuticals (ARNA) and INC Research Holdings (INCR)
www.americanbankingnews.com - August 18 at 8:10 PM |
| See what the IHS Markit Score report has to say about INC Research Holdings Inc.
finance.yahoo.com - August 14 at 10:36 PM |
| inVentiv Group Holdings, Inc. -- Moody's downgrades INC Research to Ba3; outlook stable
finance.yahoo.com - August 11 at 11:17 PM |
| ETFs with exposure to INC Research Holdings, Inc. : August 11, 2017
finance.yahoo.com - August 11 at 11:17 PM |
 | See How INC Research Holdings Ranks Among Analysts' Top Picks With Strong Buyback Activity
www.thestreet.com - August 11 at 3:59 AM |
| INC Research Holdings, Inc. (NASDAQ:INCR) Given Consensus Rating of "Hold" by Analysts
www.americanbankingnews.com - August 4 at 10:38 PM |
 | INC Research and inVentiv Health Announce Successful Completion of Merger
globenewswire.com - August 1 at 3:27 PM |
| Done deal: INC Research, inVentiv Health complete merger
finance.yahoo.com - August 1 at 3:27 PM |
| Faruqi & Faruqi, LLP Announces Filing of a Class Action Lawsuit Against INC Research Holdings, Inc.
finance.yahoo.com - July 31 at 7:16 PM |
| Brokers Offer Predictions for INC Research Holdings, Inc.'s Q2 2018 Earnings (INCR)
www.americanbankingnews.com - July 31 at 8:56 AM |
| Jefferies Group LLC Reaffirms Hold Rating for INC Research Holdings, Inc. (INCR)
www.americanbankingnews.com - July 30 at 11:38 AM |
| INC Research Holdings, Inc. :INCR-US: Earnings Analysis: Q2, 2017 By the Numbers : July 28, 2017
finance.yahoo.com - July 28 at 11:15 PM |
| INC Research Holdings, Inc. (NASDAQ:INCR) Posts Quarterly Earnings Results, Meets Expectations
www.americanbankingnews.com - July 28 at 12:20 AM |
| INC Research Reports Second Quarter 2017 Results
finance.yahoo.com - July 27 at 10:37 PM |
| Edited Transcript of INCR earnings conference call or presentation 27-Jul-17 12:00pm GMT
finance.yahoo.com - July 27 at 10:37 PM |
| INC Research meets 2Q profit forecasts
finance.yahoo.com - July 27 at 10:37 PM |
| $257.67 Million in Sales Expected for INC Research Holdings, Inc. (NASDAQ:INCR) This Quarter
www.americanbankingnews.com - July 19 at 3:46 PM |
| Zacks: Analysts Anticipate INC Research Holdings, Inc. (INCR) to Announce $0.58 Earnings Per Share
www.americanbankingnews.com - July 17 at 11:31 AM |
| Comparing INC Research Holdings (INCR) & Nektar Therapeutics (NKTR)
www.americanbankingnews.com - July 16 at 4:24 PM |
| INC Research Holdings, Inc. breached its 50 day moving average in a Bearish Manner : INCR-US : July 14, 2017
finance.yahoo.com - July 15 at 2:15 AM |
| Stull, Stull & Brody Announces Class Action Suit on Behalf of Shareholders of INC Research Holdings Inc. (NASDAQ: INCR)
finance.yahoo.com - July 14 at 3:51 AM |
| INC Research Schedules Second Quarter 2017 Earnings Call for Thursday, July 27 ...
globenewswire.com - July 11 at 11:51 PM |
| INC Research Holdings, Inc. (INCR) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - July 10 at 10:50 PM |
| INC exec: New site collaboration 'more prudent' than acquisitions
finance.yahoo.com - July 10 at 7:50 PM |
| INC Research Schedules Second Quarter 2017 Earnings Call for Thursday, July 27, 2017
finance.yahoo.com - July 10 at 7:50 PM |
| INC Research Further Expands Catalyst Program with Launch of Psychiatry Catalyst Site Network
finance.yahoo.com - July 6 at 6:00 AM |
| INC Research Holdings, Inc. (INCR) CEO Alistair Macdonald Sells 10,555 Shares
www.americanbankingnews.com - July 5 at 10:32 AM |
| INC Research Holdings, Inc. (NASDAQ:INCR) CAO Sells $400,833.36 in Stock
www.americanbankingnews.com - July 5 at 10:32 AM |
| INC Research Holdings, Inc. to Post Q1 2018 Earnings of $0.61 Per Share, Jefferies Group Forecasts (INCR)
www.americanbankingnews.com - June 30 at 9:42 AM |
| INC Research Holdings, Inc. (INCR) Lowered to Hold at Jefferies Group LLC
www.americanbankingnews.com - June 29 at 7:36 AM |
INC Research Holdings (INCR) Chart for Tuesday, September, 26, 2017
